PolyPeptide Group AG / Fundamentals
Income statement
- Net revenue
€601.35M - Cost of goods sold
€544.59M - Gross profit
€56.76M - SG&A expenses
€82.16M - R&D expenses
€2.71M - EBITDA
€20.74M - D&A
€42.05M - EBIT
-€21.30M - Interest expenses
€0.00 - EBT
-€50.68M - Tax expenses
€12.19M - Net income
-€43.67M
Cash flow statement
- Net deferred tax
€46.42M - Non-cash items
€63.45M - Changes in working capital
-€29.34M - Operating cash flow
€41.95M - Capex
€128.00M - Other investing cash flow
-€9.95M - Net investing cash flow
-€137.95M - Total cash dividends paid
-€9.67M - Issuance of common stock
€13.79M - Debt repayment
€0.00 - Other financing cash flow
€67.35M - Net financing cash flow
€57.68M - Foreign exchange effects
-€2.27M - Net change in cash
-€40.60M - Cash at end of period
€95.71M - Free cash flow
€169.94M
Balance sheet
- Cash and cash equivalents
€95.71M - Cash and short-term investments
€95.71M - Total receivables
€0.00 - Inventory
€128.51M - Other current assets
€102.39M - Total current assets
€326.60M - Property, plant & equipment
€324.11M - Goodwill
€0.00 - Intangible assets
€16.45M - Long-term investments
€5.24M - Other non-current assets
€16.69M - Total non-current assets
€362.49M - Total assets
€689.09M - Accounts payable
€60.91M - Short-term debt
€45.71M - Other current liabilities
€60.53M - Total current liabilities
€176.45M - Long-term debt
€67.96M - Deferred tax liabilities
€3.64M - Other non-current liabilities
€36.65M - Total non-current liabilities
€131.41M - Total liabilities
€307.86M - Common stock
€302.00K - Retained earnings
€165.14M - Other equity
€0.00 - Total equity
€381.23M - Total liabilities and shareholders' equity
€689.09M
Company information
- Market capitalization
€720.46M - Employees
1.4K - Enterprise Value
€768.83M
Company ratios
- Gross margin
-
9.4% Much better than peer group: -36.7% - EBITDA margin
-
3.4% Much better than peer group: -121.4% - EBIT margin
-
-3.5% Much better than peer group: -134.8% - EBT margin
-
-8.4% Much better than peer group: -139.1% - Net margin
-
-7.3% Much better than peer group: -141.4% - ROE
-
-11.5% Worse than peer group: 6.1% - ROA
-
-6.3% Worse than peer group: 1.3% - Asset turnover
-
87.3% Worse than peer group: 103.0% - FCF margin
-
-14.3% Much better than peer group: -150.7% - FCF yield
-11.9% - Efficiency ratio
96.6% - Net sales per employee
-
€441.52K - Net income per employee
-
-€32.07K